Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • olsb
    Junior Member
    • Oct 2015
    • 1

    #1

    Identifying plasmids

    I have a set of contigs, de novo assembled, from a new bacterial strain. What ways are there to identify which contigs come from plasmids? I have done the following:

    1) Used Mauve to order contigs to the core chromosome of a reference genome, and considered those contigs that were not included in the ordering as potential plasmids.

    2) Checked the GC content of each contig, with the assumption that plasmids tend to have lower GC than the core chromosome.

    3) Blastn to the nr database with each contig as query, checking if the top hit is to a core chromosome or a plasmid sequence.

    4) Checked for each contig if it contains any replication initiation gene.

    5) Made dot plots of candidate plasmids vs known plasmids (chosen based on the blastn results).

    6) Tried to run the cBar program for plasmid recognition, however could not get the program to work.



    Any suggestions for additional things to do? Or any flawed reasoning in the above steps? I got two very strong candidate plasmids based on this, but would want to be really sure before publishing.
  • HESmith
    Senior Member
    • Oct 2009
    • 512

    #2
    You've covered most of the bases; homology to known plasmids is probably the most convincing proof. Additional evidence is read depth (plasmids are generally higher copy number than the host) and circularity (reads from the 3' contig end should loop back into the 5' contig end).

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 08-11-2026, 10:35 AM
    0 responses
    11 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    30 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Working...